CMRE CMRE R2K
$15.38
+82.84% 1Y
Market & Price
Market Cap
-
Current Price
$15.38
High / Low (52W)
$17.79 / $8.40
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
14.04%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$0.62
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$3.86B
Current Assets
$690.67M
Working Capital
$292.10M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
-7.63%
Profit 5Y
-13.07%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -7.6% CAGR over 5 years.
- Earnings shrank at -13.1% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | 222.87M | -5.47M | 225.17M | 211.97M | 211.06M |
| Cost of Revenue | - | - | 87.18M | -129.76M | 95.76M | 97.91M | 98.43M |
| Gross Profit | - | - | 135.69M | 124.30M | 129.41M | 114.06M | 112.63M |
| Operating Expenses | - | - | 12.72M | 1.46M | 11.30M | 13.36M | 15.00M |
| Operating Income | - | - | 122.97M | 122.84M | 118.11M | 100.70M | 97.63M |
| EBITDA | - | - | 167.09M | 156.56M | 154.01M | 134.20M | 133.16M |
| Interest Expense | - | - | 23.57M | 17.51M | 21.99M | 21.58M | 18.42M |
| Pretax Income | - | - | 111.92M | 117.20M | 99.35M | 79.15M | 81.90M |
| Tax Provision | - | - | - | - | - | - | - |
| Net Income | - | - | 100.13M | 88.69M | 97.91M | 77.84M | 80.40M |
| Diluted EPS | - | 0.25 | 0.79 | - | 0.77 | 0.60 | 0.62 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 1.11B | 848.29M | 888.49M | 877.90M |
| Cost of Revenue | - | 513.20M | 327.30M | 340.02M | 375.07M |
| Gross Profit | - | 600.66M | 520.99M | 548.48M | 502.83M |
| Operating Expenses | - | 66.26M | 45.70M | 53.32M | 48.91M |
| Operating Income | - | 534.39M | 475.28M | 495.15M | 453.92M |
| EBITDA | - | 828.09M | 772.21M | 650.77M | 615.91M |
| Interest Expense | - | 107.20M | 126.79M | 117.07M | 89.69M |
| Pretax Income | - | 554.69M | 518.90M | 407.34M | 396.55M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | 554.96M | 385.75M | 319.92M | 364.57M |
| Diluted EPS | - | 4.26 | 2.95 | 2.44 | 2.86 |
Compounded Sales Growth
| 5 Years: | -7.63% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -13.07% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +82.84% |
| 6 Months: | +1.45% |
| 3 Months: | -11.88% |
| 1 Month: | -4.77% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 4.90B | 5.29B | 5.15B | 3.86B |
| Current Assets | - | 1.01B | 1.12B | 1.04B | 690.67M |
| Cash & Equivalents | - | 718.05M | 745.54M | 656.88M | 519.85M |
| Inventory | - | 28.04M | 61.27M | 13.16M | 14.12M |
| Receivables | - | 26.94M | 50.68M | 5.86M | 11.58M |
| Total Liabilities | - | 2.74B | 2.85B | 2.58B | 1.70B |
| Current Liabilities | - | 423.09M | 662.77M | 745.56M | 398.57M |
| Long Term Debt | - | 2.26B | 2.00B | 1.41B | 1.25B |
| Total Debt | - | 2.58B | 2.65B | 1.72B | 1.51B |
| Total Equity | - | 2.16B | 2.38B | 2.51B | 2.09B |
| Shares Outstanding | - | 127.04M | 129.38M | 130.96M | 131.59M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 581.59M | 331.37M | 537.72M | 544.27M |
| Investing Cash Flow | - | 42.49M | -120.91M | -79.51M | -169.01M |
| Financing Cash Flow | - | -166.05M | -296.81M | -505.48M | -582.92M |
| Capital Expenditure | - | -61.90M | -206.46M | -107.62M | -302.12M |
| Free Cash Flow | - | 519.70M | 124.90M | 430.10M | 242.16M |
| Net Change in Cash | - | 458.03M | 13.65M | -47.27M | -207.66M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 53.9% | 61.4% | 61.7% | 57.3% |
| Operating Margin % | - | 48.0% | 56.0% | 55.7% | 51.7% |
| Net Margin % | - | 49.8% | 45.5% | 36.0% | 41.5% |
| ROE % | - | 25.7% | 16.2% | 12.7% | 17.5% |
| ROCE % | - | 11.9% | 10.3% | 11.2% | 13.1% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CMRE
No recent headlines available.